Vaccine responses in patients with rheumatoid arthritis

被引：11

作者：

Ravikumar R. ^{[1
]}

Anolik J. ^{[1
]}

Looney R.J. ^{[1
]}

机构：

[1] University of Rochester Medical Center, Box 695, Rochester, NY 14642

来源：

Current Rheumatology Reports | 2007年 / 9卷 / 5期

关键词：

Rheumatoid Arthritis; Etanercept; Juvenile Idiopathic Arthritis; Adalimumab; Abatacept;

D O I：

10.1007/s11926-007-0065-3

中图分类号：

学科分类号：

摘要：

Rheumatoid arthritis (RA) is a systemic autoimmune disease that is associated with immunologic alterations in T cells and B cells. Moreover, many of the agents used in RA patients are potentially immunosuppressive. Thus, the underlying disease and treatment may both increase the susceptibility to infections and decrease vaccine responses. With the growing use of aggressive therapies for RA, including anti-tumor necrosis factor agents and newer biologic therapies such as rituximab and abatacept, an increasing concern will be that patients may not respond to conventional vaccination. Further prospective studies on response to vaccination are needed to answer this important public health question. Nevertheless, it is already clear that vaccination does induce response in many patients. Unfortunately, vaccination is underutilized in RA patients and needs to be aggressively promoted. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：407 / 415

页数：8

共 51 条

[1]

Verwilghen J., Vertessen S., Stevens E., Et al., Depressed T cell reactivity to recall antigens in rheumatoid arthritis, J Clin Immun, 10, pp. 90-98, (1990)

[2]

Berg L., Lampa J., Rogberg S., Et al., Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors, Ann Rheum Dis, 60, pp. 133-139, (2001)

[3]

Koetz K., Bryl E., Spickschen K., Et al., T cell homeostasis in patients with rheumatoid arthritis, Proc Natl Acad Sci, 97, pp. 9203-9208, (2000)

[4]

Schonland S., Lopez C., Widmann T., Et al., Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages, Proc Natl Acad Sci, 100, pp. 13471-13476, (2003)

[5]

Looney R.J., Hasan M.S., Coffin D., Et al., Hepatitis B immunization of healthy elderly adults: Relationship between naive CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant, J Clin Immunol, 21, pp. 30-36, (2001)

[6]

Govaert T.M., Thijs C.T., Masurel N., Et al., The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial, JAMA, 272, pp. 1661-1665, (1994)

[7]

Ehrenstein M., Evans J., Singh A., Et al., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy, J Exp Med, 200, pp. 277-285, (2004)

[8]

Doran M.F., Crowson C.S., Pond G.R., Et al., Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study, Arthritis Rheum, 46, pp. 2287-2293, (2002)

[9]

Doran M., Crowson C., Pond G., Et al., Predictors of infection in rheumatoid arthritis, Arthritis Rheum, 46, pp. 2294-2300, (2002)

[10]

Wolfe R., Caplan L., Michaud K., Et al., Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia, Arthritis Rheum, 54, pp. 628-634, (2006)

← 1 2 3 4 5 6 →